Camsirubicin + Pegfilgrastim to Determine MTD in ASTS

Clinical trial NCT05043649 · TERMINATED

Trial details

NCT number: NCT05043649
Sponsor: Monopar Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Soft-tissue Sarcoma

Start date: 2021-09-22
Primary completion: 2023-10-31
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.